11842 J. Am. Chem. Soc., Vol. 118, No. 47, 1996
Butts et al.
1H NMR (C6D6) δ 2.20 (m, 6H, CH), 1.19 (vq ) virtual quartet, JHP
)
PhI were found at 1569, 1011, 994, and 652. All other iodobenzene
bands were obscured by those assigned to the BArf counterion. Anal.
Calcd for C56H60BF24IP2Pt: C, 42.47; H, 3.82. Found: C, 42.74; H,
3.70.
7.2, 36H, CH3); 13C{1H} NMR (CD2Cl2) δ 26.33 (vt, JCP ) 12.7, CH),
20.77 (s, CH3); 31P{1H} NMR (C6D6) δ 61.83 (s, JPPt ) 4189.4); IR
(KBr, cm-1) ν(SO) ) 1176, 1035. Anal. Calcd for C18H42O2P2PtS:
C, 37.30; H, 7.30. Found: C, 37.38; H, 7.25.
[(PiPr3)2Pt(H)(η1-BrPh)]BArf (5). Inside the drybox the Et2O
complex 2 (69.0 mg, 5.00 × 10-5 mol) was dissolved in 0.8 mL of
CH2Cl2. Bromobenzene (125 µL, 1.187 mmol, 24 equiv) was then
added by syringe. The yellow solution was layered with 1 mL of
hexane and placed in a -30 °C freezer. Very pale yellow crystals
were isolated after 1 day (46 mg, 60% yield). The static complex 5
was not observed by NMR spectroscopy (see Results). The following
data represent the solvent exchange averaged resonances when seven
equivalents of PhBr were added to 3 in CD2Cl2: 1H NMR (CD2Cl2,
-58 °C) δ 7.48 (d, J ) 8.0, 2H, Ph), 7.32 (m, 1H, Ph), 7.25 (vt, J )
7.6, 2H, Ph), 2.24 (m, 6H, CH), 1.19 (vq, J ) 7.2, 36H, CH3), -20.74
(br, JHPt ) 1781, 1H, PtH); 13C{1H} NMR (CD2Cl2, -10 °C) δ 131.78
(s, Ph), 130.61 (s, Ph), 130.58 (s, Ph), 26.01 (br, CH), 20.04 (br m,
CH3); the signals for BArf were identical to those for 2; 31P{1H} NMR
(CD2Cl2, -58 °C) δ 52.28 (s, JPPt ) 2627); IR (mineral oil, cm-1):
peaks for bound PhBr were found at 1571, 1017, 998, and 457. All
other bromobenzene peaks were obscured by those assigned to the BArf
counterion. The instability of 5 prevented a satisfactory elemental
analysis.
[(PiPr3)2Pt(H)(OEt2)]BArf (2). (PiPr3)2Pt(SO2) (254 mg, 0.438
mmol) was added to a 100 mL Schlenk flask followed by 20 mL of
Et2O in the drybox. A separate 25 mL Schlenk flask was charged with
469 mg of HBArf (0.463 mmol) and 15 mL of Et2O. Hexane (25 mL)
was added to a third flask. The three flasks were fitted with septa and
flushed with argon on a Schlenk line. The green solution containing
the platinum complex was cooled to -78 °C in a dry ice/acetone bath
after which the HBArf solution was added slowly by cannula under
argon. The solution immediately turned yellow and was stirred at -78
°C for 15 min. The hexane was then added under argon by syringe.
The resulting solvent mixture was reduced to 25 mL under vacuum
during which time yellow powder precipitated. After allowing the
mixture to stand at -78 °C for 30 min, the pale yellow solution was
decanted by syringe. The remaining yellow powder was dried under
vacuum (595 mg, 93% yield): 1H NMR (CD2Cl2, -83 °C) δ 7.72 (s,
8H, BArf), 7.53 (s, 4H, BArf), 3.74 (q, J ) 6.8, 4H, ether CH2), 2.24
(br, 6H, CH), 1.30 (t, JHH ) 6.8, 6H, ether CH3), 1.13 (vq, J ) 6.4,
36H, iPr CH3), -27.84 (t, JHP ) 14, JHPt ) 1540, 1H, PtH); 13C{1H}
NMR (CD2Cl2, -83 °C) δ 161.42 (q, J ) 49.0, i-BArf), 134.18 (s,
o-BArf), 128.18 (qm, JCF ) 31.1, m-BArf), 124.0 (d, JCF ) 272.8, CF3),
117.13 (s, p-BArf), 70.37 (s, CH2), 25.38 (vt, JCP ) 15.3, CH), 19.23
(s, i-Pr CH3), 14.76 (s, ether CH3); 31P{1H} NMR (CD2Cl2, -58 °C) δ
55.48 (s, JPPt ) 2748). Satisfactory elemental analysis could not be
obtained.18
{trans-[(PiPr3)2Pt(H)]2(µ-I)}BArf (6). A 25 mL bomb was charged
with 4 (193 mg, 1.22 × 10-4 mol) followed by 10 mL of Et2O in the
drybox. The closed flask was then removed from the drybox and placed
in an oil bath at 100 °C for four days, during which time the pale
yellow solution turned orange. The volatile materials were removed
under vacuum to afford a sticky orange-red solid which was washed
with hexane (2 × 8 mL) and subsequently isolated as a dark orange
powder. The powder was dissolved in 1.5 mL of CH2Cl2, layered with
1.5 mL of hexane, and placed in a -30 °C freezer. Thin yellow
hexagonal plates were isolated (colorless after a second recrystalliza-
tion). The mother liquor was pumped to dryness and a second crop
isolated by recrystallization from Et2O hexane in the same manner.
The total yield was 96 mg (39%): 1H NMR (CD2Cl2) δ 2.47 (m, 12H,
CH), 1.27 (vq, J ) 7.2, 72H, CH3), -18.40 (br, JHPt ) 1645, 2H, PtH);
13C{1H} NMR (CD2Cl2) δ 27.14 (vt, JCP ) 15.3, CH), 20.59 (s, CH3);
the signals for BArf were identical to those for 4; 31P{1H} NMR (CD2-
Cl2) δ 53.06 (s, JPPt ) 2738); FAB MS (NOBA) m/e (relative intensity)
1159 ([M - BArf]+, 40), 516 ([M - (PiPr3)2Pt(H)(I) - BArf]+, 100).
[(PiPr3)2Pt(H)(THF)]BArf (7). Complex 2 (40 mg, 2.75 × 10-5
mol) was dissolved in 0.8 mL of THF in the drybox. The solution
was then layered with 1 mL of hexane. After allowing the solution to
stand overnight in a -30 °C freezer, colorless crystals of 7 were isolated
which were dried under vacuum (31 mg, 78% yield): 1H NMR (CD2-
Cl2) δ 3.84 (m, 4H, CH2), 2.32 (m, 6H, CH), 1.94 (m, 4H, CH2), 1.29
(vq, J ) 7.2, 36H, CH3), -27.88 (-10 °C, br, JHPt ) 1524, 1H, PtH);
13C{1H} NMR (CD2Cl2, -10 °C) δ 74.38 (br s, THF), 26.12 (vt, JCP
) 14.6, CH), 25.60 (s, THF), 20.10 (s, CH3); the signals for BArf were
[(PiPr3)2Pt(H)(η1-ClCH2Cl)]BArf (3). Method A. Complex 3 was
isolated by recrystallizing the Et2O complex 2 from CH2Cl2/hexane.
For example, 3 was isolated as yellow plates (517 mg, 80% yield) when
a CH2Cl2 solution of 2 (642 mg in 4 mL) was layered with 8 mL of
hexane and allowed to stand at -30 °C overnight. The deuterium
analog was prepared by substituting CD2Cl2 for CH2Cl2. The static
complex 3 was not observed by NMR spectroscopy (see Results). The
following data represent the solvent exchange averaged resonances
when 3 was dissolved in CD2Cl2: 1H NMR (CD2Cl2, -58 °C) δ 2.34
(m, 6H, CH), 1.19 (m, 36H, CH3), -22.82 (t, JHP ) 11.9, JHPt ) 1852,
1H, PtH); 13C{1H} NMR (CD2Cl2, -78 °C) δ 24.51 (m, CH), 19.17
1
(s, CH3), the H and 13C resonances attributed to the counterion were
identical to those reported for 2; 31P{1H} NMR (CD2Cl2, -58 °C) δ
54.61 (s, JPPt ) 2637); IR (mineral oil, cm-1) ν(CCl)asym ) 751, ν-
(CCl)sym ) 663. Satisfactory elemental analysis could not be obtained
due to the instability of the compound toward CH2Cl2 loss.
Method B. In the drybox trans-(PiPr3)2Pt(H)(Cl) (754 mg, 1.37
mmol) was dissolved in 25 mL of CH2Cl2 (see note in general section
of the Experimental Section) in a round bottom flask. NaBArf51 (1.26
g, 1.42 mmol) was then added as a solid with stirring. The
homogeneous yellow solution quickly turned cloudy orange and was
allowed to stir at room temperature for 2 h. The mixture was filtered
through Celite to remove the NaCl, reduced in volume under vacuum
to 4 mL, layered with 6 mL of hexane, and placed in a -30 °C freezer.
Yellow crystalline 3 was isolated in 63% yield.
[(PiPr3)2Pt(H)(η1-IPh)]BArf (4). This reaction was performed in
the drybox. The Et2O complex 2 (123 mg, 8.05 × 10-5 mol) was added
to a 50 mL round bottom flask with a stir bar and dissolved in 15 mL
of dichloromethane. A solution of iodobenzene (103 mg, 0.505 mmol,
6.3 equiv) was added slowly with stirring. After standing at room
temperature for 3 h the volume was reduced to 5 mL. This yellow
solution was layered with 5 mL of hexane and placed in a -30 °C
freezer. Over 12 h time, colorless crystals precipitated (122 mg, 87%
yield) which were dried under vacuum: 1H NMR (CD2Cl2) δ 7.72 (s,
8H, BArf), 7.56 (s, 4H, BArf), 7.66 (d, J ) 8.1, 2H, Ph), 7.51 (t, J )
7.2, 1H, Ph), 7.26 (vt, J ) 7.6, 2H, Ph), 2.30 (m, 6H, CH), 1.24 (vq,
J ) 7.2, 36H, CH3), -17.02 (vbr, JHPt ) 1650, 1H, PtH) (at -93 °C,
the hydride appeared as a triplet at -15.89 (JHP ) 9, JHPt ) 1654));
13C{1H} NMR (CD2Cl2) δ 161.99 (q, J ) 49.8, i-BArf), 137.21 (s,
Ph), 135.08 (s, o-BArf), 131.61 (s, Ph), 130.77 (s, Ph), 129.20 (q, JCF
) 31.5, m-BArf), 124.90 (d, JCF ) 271.7, CF3), 117.76 (s, p-BArf),
27.05 (vt, JCP ) 15.0, CH2), 20.38 (s, CH3); 31P{1H} NMR (CD2Cl2)
δ 53.03 (s, JPPt ) 2603.8); IR (mineral oil, cm-1): peaks for bound
identical to those for 4; 31P{1H} NMR (CD2Cl2) δ 57.10 (s, JPPt
)
2755). Anal. Calcd for C54H63BF24OP2Pt: C, 44.67; H, 4.37.
Found: C, 44.89; H, 4.39.
[(P-t-Bu3)2Pt(H)]BArf. In the drybox, trans-(P-t-Bu3)2Pt(H)(Cl)
(639 mg, 1.00 mmol) was added to a round bottom flask with a stir
bar. Diethyl ether (20 mL) was added to form a pale yellow suspension.
To this was added NaBArf57 (901 mg, 1.02 mmol) piecewise as a solid
with stirring during which time the mixture turned yellow-orange. After
stirring at room temperature for two hours, the volatile materials were
removed under vacuum and the resulting yellow powder was extracted
with 25 mL of CH2Cl2. The dark orange mixture was filtered through
Celite to remove the NaCl and concentrated under vacuum to 16 mL.
This solution was layered with 16 mL of hexane and placed in a -30
°C freezer. Pure [(P-t-Bu3)2Pt(H)]BArf was isolated as a yellow powder
in 64% yield (941 mg): 1H NMR (CD2Cl2) δ 1.51 (vt, J ) 6.4, 54H,
t-Bu), -36.53 (t, JHP ) 8.0, JHPt ) 2605, 1H, PtH); 13C{1H} NMR
(CD2Cl2) δ 41.07 (t, JCP ) 8.9, C(CH3)3), 32.75 (s, C(CH3)3); the signals
for BArf were identical to those for 4; 31P{1H} NMR (CD2Cl2) δ 87.14
(s, JPPt ) 2625). Anal. Calcd for C56H67BF24P2Pt: C, 45.95; H, 4.61.
Found: C, 46.11; H, 4.55.
Reaction of 3 with H2. Complex 3 (15 mg, 1.02 × 10-5 mol) was
loaded into an NMR tube followed by 0.5 mL of CD2Cl2 in the drybox.